Polyneuropathy

Neurology·MeSH: Polyneuropathies

31 drugs in development·14 companies·2 clinical trials

Drug Pipeline by Phase

Approved(12)

Drug	Company
Amvuttra	Royalty Pharma plc (RPRX)
AMVUTTRA	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
cutaquig	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
cuvitru	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
gammagard liquid	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
hizentra	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
hyqvia	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
ONPATTRO	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
tegsedi	AKCEA THERAPEUTICS, INC. (AKCA)
Tegsedi	PTC THERAPEUTICS, INC. (PTCT)
wainua	ASTRAZENECA PLC (AZN)
xembify	KORU Medical Systems Inc. Common Stock (DE) (KRMD)

Phase 3(14)

Drug	Company
Batoclimab	Immunovant, Inc. (IMVT)
claseprubart	Dianthus Therapeutics, Inc. /DE/ (DNTH)
Empasiprubart	ARGENX SE (ARGX)
Empasiprubart IV	ARGENX SE (ARGX)
eplontersen	IONIS PHARMACEUTICALS INC (IONS)
ivig	Sanofi (SNY)
IVIg	Sanofi (SNY)
IVIG	ARGENX SE (ARGX)
Nucresiran	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
riliprubart	Sanofi (SNY)
riliprubart	Sanofi (SNY)
riliprubart prefilled pen	Sanofi (SNY)
Riliprubart Prefilled Pen	Sanofi (SNY)
Vutrisiran	ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Phase 2(1)

Drug	Company
imeroprubart	Immunovant, Inc. (IMVT)

Phase 1(1)

Drug	Company
NTLA-2001	Intellia Therapeutics, Inc. (NTLA)

Preclinical(1)

Drug	Company
ag10	Eidos Therapeutics, Inc. (EIDX)

Phase 2/Phase 3(1)

Drug	Company
imvt-1402	Roivant Sciences Ltd. (ROIV)

Phase 4(1)

Drug	Company
Efgartigimod PH20 SC	ARGENX SE (ARGX)

BioSniper tracks 31 drugs in development for Polyneuropathy across 14 companies.

There are 2 clinical trials targeting Polyneuropathy tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.